# Taiwan FDA Audits Magnesium and Calcium Carbonate: 23 Drug Products Fail, Yuncheng and Yixing Supplied Materials Breaching Pharmacopoeia Limits for Arsenic, Iron and Calcium Oxide

> Taiwan's Food and Drug Administration investigated magnesium carbonate and calcium carbonate supplied by Yuncheng and Yixing and found 23 products from 13 of 27 drug makers were made with food-grade or food-additive raw materials instead of pharmaceutical grade. Samples of the magnesium carbonate failed pharmacopoeia standards for arsenic, iron, calcium oxide and assay, and the FDA has halted sales of the affected inventory.

- Date: 2026-11-21 · published 2026-11-21T06:18:50.212Z
- Category: policy · region Taiwan · magnitude low
- Page: https://feedsoft.ai/events/112089-taiwan-fda-audits-magnesium-and-calcium-carbonate-23-drug-products-fail
- Commodities: [Magnesium Oxide](https://feedsoft.ai/c/MGO.md)

## Why it matters

This is a domestic pharmaceutical raw-material compliance action with no measurable effect on feed grain, protein or mineral supply or prices. It is unlikely to move feed-grade magnesium or calcium carbonate markets.

## Sources

- nongxun.net: https://www.nongxun.net/wdd911430

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.
